San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and upcoming Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA.
» Full Video and Article
Reporter Bradley J. Fikes from The San Diego Union Tribune interviewed Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD for a Q&A: Inside Biotech for the Business Section. The interview discusses her role at MCC, bridging the gap between researchers and industry to create collaborations. Building Bridges to Rx (PDF)
September 9, 2013
Sunrise 7's Sean Caldwell spoke with Moores Cancer Center Deputy Director for Research Dr. Thomas J. Kipps and Donald Sutherland, a man diagnosed with chronic lymphocytic leukemia (CLL) to help understand the constantly changing language of cancer.
» Full article and video
April 11, 2013
San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.
» Full video
2015 Symposium: Save the Date!
Our 11th Annual Moores Cancer Center Industry/Academia Translational Oncology Symposium will be taking place on Thursday February 19, 2015.
Elaine R. Mardis, PhD
The Genome Institute
Washington University School of Medicine
Brian Druker, MD
OHSU Knight Cancer Institute
Ricardo Attar, PhD
Janssen Research & Development
Chris Boshoff, MD, PhD, FMedSci
Napoleone Ferrara, MD
Moores Cancer Center
Richard Schwab, MD
Moores Cancer Center
Stay tuned for updates as more information becomes available.
10th Anniversary Translational Oncology Symposium
A decade of fostering collaborations, fueling innovation & saving lives
Thursday, February 20, 2014
UCSD Moores Cancer Center | 8AM - 6PM
San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see below.
Xconomy’s San Diego Life Sciences Roundup included Bob Klein’s Proposal presented at the Moores Cancer Center Symposium, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016. » Read Here
Xconomy's San Diego Life Sciences Roundup also included the Moores Cancer Center Symposium and Laura Esserman's acceptance of the Duane Roth Award. » Read Here
The San Diego Daily Transcript published an article about Dr. Esserman's acceptance of the Duane Roth Award and the Symposium. » Read Here
The San Diego Union Tribune wrote an article on the Symposium, namely the iSPY Trial and patient from the trial, San Diego Resident Heather Clark. » Read Here
Symposium Speaker Bob Klein was featured in a San Diego Union Tribune article, outlining the $5 billion ballot initiative for funding California Institute for Regenerative Medicine in 2016, presented at the Moores Cancer Center Symposium. » Read Here
Learn more about our Principal Investigators here at Moores Cancer Center, including their Translational Oncology Research and toolbox of models they use. For all interviews, please see the Principal Investigators page.
Dr. Harismendy has a decade of experience in functional genomics and has been working in translational genomics for the past six years, developing assays and analysis for targeted sequencing, exploring the role of regulatory variants in common diseases, and improving the detection of somatic mutations in cancer. Most recently, he has been implementing an Ultra Deep Targeted Sequencing assay to detect low-prevalence mutations in clinical samples, with the intent of advancing research to ultimately provide a comprehensive personalized molecular profile of solid tumors.
David Cheresh, PhD, Professor of Medicine, Associate Director for Research Education and Training
Dr. Howell is a tenured Professor of Medicine with more than 35 years of experience as a principal investigator in basic science, translational research, and both investigator-initiated and industry-initiated clinical research. Over the past decade, he has focused on understanding the cellular pharmacology of platinum drugs, a class of chemotherapy drugs that trigger cell death in cancerous tumors, and the development of additional drug delivery systems for platinum-containing chemotherapeutic agents.
David Vera, PhD, Professor of Radiology and Surgery, Co-Director, UCSD Molecular Imaging Program
Dr. Vera's principal focus is the design and synthesis of targeted diagnostic agents capable of measuring receptor density and affinity. His current research uses receptor-binding technology for sentinel node mapping of melanoma, breast, GI, and urologic cancers. The new agent, Tc-99m-DTPA-mannosyl-dextran (also called Lymphoseek or the generic name, tilmanocept), developed in collaboration with UCSD clinicians and surgeons, recently completed in a Phase III multi-center clinical trial for breast cancer and melanoma.
Dr. Bejar is Assistant Professor of Medicine in the Division of Hematology-Oncology. His lab is focused on understanding the genetic changes that drive the development and progression of hematologic malignancies like acute myeloid leukemia and myelodysplastic syndromes. His goal is to translate discoveries into clinically meaningful improvements in patient care with these disorders.
Dr. Choi is a hematologist and medical oncologist specializing in the treatment of patients with blood cancers and other blood disorders, with an emphasis on chronic lymphocytic leukemia (CLL). He is a part of UC San Diego's CLL research team, collaborating with the laboratories of Drs. Thomas Kipps, Januario Castro, and Dennis Carson to help develop new therapies for patients with blood cancers. His clinical research interests include highly targeted novel therapies that can be used to treat blood cancers in a personalize and molecularly-driven manner.
San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.